Daunorubicin Drug

Product Details:

Indication Anticancer drug; used for the treatment of leukemia and other types of cancer
Dosage Form Powder for Injection
Salt Composition Daunorubicin Hydrochloride
Enzyme Types
Feature Sterile, lyophilized powder for injection
Ingredients Daunorubicin Hydrochloride
Application Medical/Pharmaceutical; Intravenous use
Share Your Product:

Get a Price/Quote

Request To Call Back Send Inquiry

Daunorubicin Drug Product Specifications

Physical Color/Texture Reddish-orange powder
Ingredients Daunorubicin Hydrochloride
Shelf Life 2 years
Feature Sterile, lyophilized powder for injection
Storage Instructions Store below 25C; protect from light
Ph Level 3.0 to 6.0 (after reconstitution)
Dosage Form Powder for Injection
Salt Composition Daunorubicin Hydrochloride
Fermentation Smell Odorless
Application Medical/Pharmaceutical; Intravenous use
Indication Anticancer drug; used for the treatment of leukemia and other types of cancer

Packaging Size Typically 20 mg/vial or as specified
Contraindications Patients with severe hepatic impairment, hypersensitivity to daunorubicin or anthracyclines
Molecular Formula C27H29NO10HCl
Route of Administration Intravenous (IV)
Warning Cytotoxichandle with care; for hospital and oncology use only
USP Standard Meets or exceeds USP quality requirements
Purity >98%
Molecular Weight 563.99 g/mol
CAS Number 23541-50-6
Therapeutic Class Anthracycline antibiotic cytotoxic agent

Product Description

Daunorubicin Injection is administered via intravenous route by trained physician or nurse. It is indicated to be used for treatment of blood cancer including AML, ALL, and CML. This chemical is known to work by interacting with DNA by intercalation and inhibiting macromolecular biosynthesis. It gets metabolized in liver with elimination half-life of about 26.7 hours and excretion via biliary system & in urine. This injection is also known to work by inhibiting topoisomerase II progression resulting in prevention of transcription. Daunorubicin Injection is known to belong to anthracycline class of medicines and is suitable for treatment of Kaposis sarcoma.

Product Details:

Minimum Order Quantity	1000 Unit
Usage	Commercial, Clinical

We are leading exporter and manufacturer of Daunorubicin Injection.

Uses

Daunorubicin is used in the treatment of blood cancer

How it works

Daunorubicin works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.

Common side effects

Nausea, Vomiting, Reduced blood platelets, Ulcer, Infection, Abdominal pain, Loss of appetite, Decreased white blood cell count, Hair loss, Fever, Decreased blood cells (red cells, white cells, and platelets), Fatigue, Anemia, Chills, Diarrhoea, Mucosal inflammation, Febrile neutropenia, Stomatitis (Inflammation of the mouth), Breathing difficulty

Daunorubicin Injection exporter, Daunorubicin Injection manufacturer

Daunorubicin Injection supplier, Daunorubicin Injection manufacturer in India,

Daunorubicin Injection exporter in India.

Potent Anthracycline for Oncology

Daunorubicin Hydrochloride plays a critical role in cancer therapy, harnessed for its efficacy in treating leukemia and various other cancers. It functions by inhibiting DNA synthesis in malignant cells, contributing significantly to chemotherapeutic regimens in major healthcare institutions.

Premium Quality and Safety Compliance

Conforming to USP standards and boasting a purity over 98%, Daunorubicin Hydrochloride undergoes stringent quality checks. Its cytotoxic nature necessitates careful handling by healthcare professionals, ensuring safety during preparation and administration.

Convenient Packaging and Storage

Available commonly in 20 mg vials, Daunorubicin Hydrochloride is a sterile, lyophilized powder designed for easy reconstitution. For optimal longevity and stability, store the vials below 25C and protect them from light, preserving the drugs therapeutic efficacy for up to two years.

FAQs of Daunorubicin Drug:

Q: How is Daunorubicin Hydrochloride administered to patients?

A: Daunorubicin Hydrochloride is administered as an intravenous (IV) injection, typically by a trained healthcare professional in a hospital or oncology clinic setting. The dosage and frequency depend on the treatment protocol and patient condition.

Q: What types of cancer is Daunorubicin Hydrochloride commonly used to treat?

A: Daunorubicin Hydrochloride is predominantly indicated for treating leukemia, especially acute forms, and is also utilized in protocols for other cancers as determined by oncologists.

Q: When should Daunorubicin not be used?

A: It is contraindicated in patients with severe hepatic impairment or those with a known hypersensitivity to daunorubicin or other anthracyclines. Always consult a specialist before initiating therapy.

Q: Where should Daunorubicin Hydrochloride vials be stored to maintain quality?

A: Store Daunorubicin Hydrochloride vials below 25C and shield them from light exposure. Proper storage preserves the potency and safety of the drug throughout its shelf life.

Q: What process should be followed when preparing Daunorubicin for injection?

A: The lyophilized powder must be reconstituted with a suitable solvent under sterile conditions by qualified healthcare personnel, ensuring correct pH and concentration for safe intravenous administration.

Q: How does Daunorubicin benefit cancer patients?

A: As a cytotoxic agent, Daunorubicin works by interfering with DNA replication in cancer cells, reducing proliferation and contributing to remission, particularly in leukemic patients.

Q: What precautionary measures must be observed while handling Daunorubicin Hydrochloride?

A: Given its cytotoxicity, Daunorubicin Hydrochloride must be handled with specialized protective equipment in medical facilities. Preparation and administration should be performed by trained professionals to prevent exposure and ensure safety.